Tender Details
Tender Title / Description
| Tender Title | Re-tender for the procurement of drugs for the year 2026-27 |
|---|---|
| Tender Description | activated charcoal ip 10 gm acyclovir eye ointment ip 3% w/w acyclovir suspension ip 400 mg/5 ml allopurinol tab ip 100 mg amiodarone sterile concentrate ip 50 mg/ml amoxycillin + potassium clavulanate suspension each ml of reconstituted suspension contains; amoxycillin trihydrate ip equivalent to amoxicillin 80mg and potassium clavunate ip equivalent to clavulanic acid 11.4 mg atropine eye drops bp/usp 1% atropine eye ointment ip 1% w/w azithromycin inj 500 mg bisacodyl suppository ip 5 mg calcium gluconate inj ip 10% w/v carbamazepine suspension bp/usp 100 mg/5 ml carvedilol tab ip 25 mg clomiphene citrate tab ip 50 mg clomipramine cap ip 25 mg clomipramine tab 75 mg co-trimoxazole suspension ip 40 mg + 200 mg desferrioxamine inj ip 500 mg dexamethasone eye drops bp 0.1% dexamethasone tab ip 0.5 mg diazepam inj ip 5 mg/ml diazepam suppository 5 mg digoxin inj ip 0.5 mg/2 ml diltiazem inj ip 5 mg/ml enoxaparin injection ip (low molecular weight heparin inj) 40 mg/0.4 ml fe |
| Comments | activated charcoal ip 10 gm acyclovir eye ointment ip 3% w/w acyclovir suspension ip 400 mg/5 ml allopurinol tab ip 100 mg amiodarone sterile concentrate ip 50 mg/ml amoxycillin + potassium clavulanate suspension each ml of reconstituted suspension contains; amoxycillin trihydrate ip equivalent to amoxicillin 80mg and potassium clavunate ip equivalent to clavulanic acid 11.4 mg atropine eye drops bp/usp 1% atropine eye ointment ip 1% w/w azithromycin inj 500 mg bisacodyl suppository ip 5 mg calcium gluconate inj ip 10% w/v carbamazepine suspension bp/usp 100 mg/5 ml carvedilol tab ip 25 mg clomiphene citrate tab ip 50 mg clomipramine cap ip 25 mg clomipramine tab 75 mg co-trimoxazole suspension ip 40 mg + 200 mg desferrioxamine inj ip 500 mg dexamethasone eye drops bp 0.1% dexamethasone tab ip 0.5 mg diazepam inj ip 5 mg/ml diazepam suppository 5 mg digoxin inj ip 0.5 mg/2 ml diltiazem inj ip 5 mg/ml enoxaparin injection ip (low molecular weight heparin inj) 40 mg/0.4 ml fe |
Important Dates
| Published Date | |
|---|---|
| Due Date | 11 May 2026 00:00:00 |
Estimate and EMD
| Estimated Value | 0.0 |
|---|---|
| EMD | 0 INR |
| Processing Fee | 0 INR |